Ubs Group Ag Laboratory Corp Of America Holdings Call Options Transaction History

Ubs Group Ag

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 09, 2023	SELL	$201.05 - $221.7 $2.61 Million - $2.88 Million	-13,000 Reduced 46.43%	15,000 $3.02 Million
Q3 2022 Nov 10, 2022	BUY	$204.81 - $262.19 $5.73 Million - $7.34 Million	28,000 New	28,000 $5.74 Million
Q3 2019 Nov 14, 2019	SELL	$159.77 - $178.1 $8.58 Million - $9.56 Million	-53,700 Reduced 80.51%	13,000 $2.18 Million
Q2 2019 Aug 14, 2019	BUY	$144.16 - $172.9 $6.73 Million - $8.07 Million	46,700 Added 233.5%	66,700 $11.5 Million
Q3 2018 Nov 14, 2018	SELL	$167.67 - $188.27 $4.09 Million - $4.59 Million	-24,400 Reduced 54.95%	20,000 $3.47 Million
Q2 2018 Aug 14, 2018	BUY	$160.33 - $189.41 $5.92 Million - $6.99 Million	36,900 Added 492.0%	44,400 $7.97 Million
Q2 2017 Aug 14, 2017	BUY	N/A	7,500	7,500 $1.16 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.